BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21207936)

  • 1. Defining CYP3A4 structural responses to substrate binding. Raman spectroscopic studies of a nanodisc-incorporated mammalian cytochrome P450.
    Mak PJ; Denisov IG; Grinkova YV; Sligar SG; Kincaid JR
    J Am Chem Soc; 2011 Feb; 133(5):1357-66. PubMed ID: 21207936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4.
    Denisov IG; Mak PJ; Grinkova YV; Bastien D; Bérubé G; Sligar SG; Kincaid JR
    J Inorg Biochem; 2016 May; 158():77-85. PubMed ID: 26774838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane-embedded substrate recognition by cytochrome P450 3A4.
    Hackett JC
    J Biol Chem; 2018 Mar; 293(11):4037-4046. PubMed ID: 29382727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric mechanisms in cytochrome P450 3A4 studied by high-pressure spectroscopy: pivotal role of substrate-induced changes in the accessibility and degree of hydration of the heme pocket.
    Davydov DR; Baas BJ; Sligar SG; Halpert JR
    Biochemistry; 2007 Jul; 46(26):7852-64. PubMed ID: 17555301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: ligand binding and spin state equilibria.
    Roberts AG; Campbell AP; Atkins WM
    Biochemistry; 2005 Feb; 44(4):1353-66. PubMed ID: 15667229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revealing substrate-induced structural changes in active site of human CYP51 in the presence of its physiological substrates.
    Jing Y; Usai R; Liu Y; Kincaid JR
    J Inorg Biochem; 2023 May; 242():112167. PubMed ID: 36870163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The one-electron autoxidation of human cytochrome P450 3A4.
    Denisov IG; Grinkova YV; McLean MA; Sligar SG
    J Biol Chem; 2007 Sep; 282(37):26865-26873. PubMed ID: 17650504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexible structure of cytochrome P450: promiscuity of ligand binding in the CYP3A4 heme pocket.
    Ohkura K; Kawaguchi Y; Watanabe Y; Masubuchi Y; Shinohara Y; Hori H
    Anticancer Res; 2009 Mar; 29(3):935-42. PubMed ID: 19414330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency.
    Polic V; Sevrioukova IF; Auclair K
    Arch Biochem Biophys; 2018 Sep; 653():90-96. PubMed ID: 29958895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Studies of Cytochrome P450 3A4 Time-Dependent Inhibition Using Two Cysteine-Targeting Electrophiles.
    Barr JT; Wang Z; Min X; Wienkers HJ; Rock BM; Rock DA; Wienkers LC
    Drug Metab Dispos; 2020 Jun; 48(6):508-514. PubMed ID: 32193357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of CYP3A4 with caffeine: First insights into multiple substrate binding.
    Sevrioukova IF
    J Biol Chem; 2023 Sep; 299(9):105117. PubMed ID: 37524132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resonance Raman studies of cytochrome P450 2B4 in its interactions with substrates and redox partners.
    Mak PJ; Im SC; Zhang H; Waskell LA; Kincaid JR
    Biochemistry; 2008 Mar; 47(12):3950-63. PubMed ID: 18311926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Dynamics of Cytochrome P450 3A4 in the Presence of Substrates and Cytochrome P450 Reductase.
    Ducharme J; Sevrioukova IF; Thibodeaux CJ; Auclair K
    Biochemistry; 2021 Jul; 60(28):2259-2271. PubMed ID: 34196520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site.
    Dabrowski MJ; Schrag ML; Wienkers LC; Atkins WM
    J Am Chem Soc; 2002 Oct; 124(40):11866-7. PubMed ID: 12358527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
    Kang P; Liao M; Wester MR; Leeder JS; Pearce RE; Correia MA
    Drug Metab Dispos; 2008 Mar; 36(3):490-9. PubMed ID: 18096676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of heterotropic cooperativity in cytochrome P450 3A4 using alpha-naphthoflavone and testosterone.
    Frank DJ; Denisov IG; Sligar SG
    J Biol Chem; 2011 Feb; 286(7):5540-5. PubMed ID: 21177853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4.
    Isin EM; Guengerich FP
    J Biol Chem; 2006 Apr; 281(14):9127-36. PubMed ID: 16467307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexibility of human cytochrome P450 enzymes: molecular dynamics and spectroscopy reveal important function-related variations.
    Hendrychová T; Anzenbacherová E; Hudeček J; Skopalík J; Lange R; Hildebrandt P; Otyepka M; Anzenbacher P
    Biochim Biophys Acta; 2011 Jan; 1814(1):58-68. PubMed ID: 20656072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resonance Raman investigations of Escherichia coli-expressed Pseudomonas putida cytochrome P450 and P420.
    Wells AV; Li P; Champion PM; Martinis SA; Sligar SG
    Biochemistry; 1992 May; 31(18):4384-93. PubMed ID: 1581294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.
    Sevrioukova IF; Poulos TL
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.